NASDAQ : TKNO
Alpha Teknova, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 8.09 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 499.17M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Alpha Teknova, Inc. (TKNO) reported revenue of 43.70M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 43.70M | 40.52M | 37.74M | 36.68M | 41.42M | 36.89M |
| Cost of Revenue | 28.58M | 27.08M | 30.51M | 26.39M | 23.94M | 19.27M |
| Gross Profit | 15.12M | 13.44M | 7.23M | 10.30M | 17.48M | 17.62M |
| Selling, General & Admin | 27.06M | 26.57M | 28.07M | 33.38M | 37.45M | 24.17M |
| Research & Development | 2.23M | 2.20M | 2.76M | 5.57M | 7.74M | 4.31M |
| Amortization of Goodwill & Intangibles | 1.15M | 1.15M | 1.15M | 1.15M | 1.15M | 1.15M |
| Operating Expenses | 30.43M | 29.92M | 31.98M | 40.09M | 46.33M | 29.63M |
| Operating Income | -15.31M | -16.48M | -24.75M | -29.80M | -28.86M | -12.01M |
| Interest Expense | -872.00K | -710.00K | -687.00K | -833.00K | -589.00K | |
| Interest & Investment Income | 213.00K | |||||
| Other Non Operating Income (Expenses) | 11.00K | 485.00K | 142.00K | 55.00K | -40.00K | |
| EBT Excluding Unusual Items | -16.18M | -16.70M | -25.43M | -30.49M | -28.59M | -12.64M |
| Merger & Restructuring Charges | -1.30M | -700.00K | ||||
| Impairment of Goodwill | -16.61M | |||||
| Asset Writedown | -4.36M | -4.19M | ||||
| Other Unusual Items | -500.00K | -500.00K | -100.00K | -1.52M | ||
| Pretax Income | -16.68M | -17.20M | -26.83M | -37.08M | -49.39M | -12.64M |
| Income Tax Expense | 94.00K | 58.00K | -88.00K | -298.00K | -1.92M | -2.83M |
| Earnings From Continuing Operations | -17.26M | -26.75M | -36.78M | -47.47M | -9.80M | |
| Net Income | -16.77M | -17.26M | -26.75M | -36.78M | -47.47M | -9.80M |
| Net Income to Common | -16.77M | -17.26M | -26.75M | -36.78M | -47.47M | -9.80M |
| Shares Outstanding (Basic) | 53.57M | 53.48M | 46.75M | 31.82M | 28.08M | 16.09M |
| Shares Outstanding (Diluted) | 53.57M | 53.48M | 46.75M | 31.82M | 28.08M | 16.09M |
| EPS (Basic) | -0.31 | -0.32 | -0.57 | -1.16 | -1.69 | -0.61 |
| EPS (Diluted) | -0.31 | -0.32 | -0.57 | -1.16 | -1.69 | -0.61 |
| Free Cash Flow | -7.35M | -9.79M | -13.52M | -26.75M | -55.55M | -28.95M |
| Free Cash Flow Per Share | -0.14 | -0.18 | -0.29 | -0.84 | -1.98 | -1.80 |
| Gross Margin | 34.60% | 33.17% | 19.16% | 28.07% | 42.19% | 47.76% |
| Operating Margin | -35.04% | -40.66% | -65.56% | -81.23% | -69.67% | -32.55% |
| Profit Margin | -38.37% | -42.59% | -70.86% | -100.26% | -114.60% | -26.57% |
| Free Cash Flow Margin | -16.83% | -24.17% | -35.81% | -72.91% | -134.11% | -78.46% |
| EBITDA | -8.97M | -10.13M | -18.17M | -24.14M | -25.69M | -9.12M |
| EBITDA Margin | -20.53% | -25.01% | -48.13% | -65.80% | -62.03% | -24.73% |
| D&A For EBITDA | 6.34M | 6.34M | 6.58M | 5.66M | 3.17M | 2.88M |
| EBIT | -15.31M | -16.48M | -24.75M | -29.80M | -28.86M | -12.01M |
| EBIT Margin | -35.04% | -40.66% | -65.56% | -81.23% | -69.67% | -32.55% |
| Advertising Expenses | 100.00K | 100.00K | 400.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 6.00M | 5.91M | 3.71M | 28.48M | 42.24M | 87.52M |
| Short-Term Investments | 11.43M | 15.43M | 26.69M | |||
| Cash & Short-Term Investments | 17.44M | 21.34M | 30.40M | 28.48M | 42.24M | 87.52M |
| Accounts Receivable | 5.41M | 4.62M | 4.31M | 3.95M | 4.26M | 4.67M |
| Other Receivables | 22.00K | 1.19M | ||||
| Receivables | 5.41M | 4.62M | 4.31M | 3.95M | 4.28M | 5.85M |
| Inventory | 6.91M | 7.05M | 6.80M | 11.59M | 12.25M | 5.39M |
| Prepaid Expenses | 1.07M | 1.50M | 1.27M | 1.63M | 2.37M | 2.44M |
| Total Current Assets | 30.82M | 34.51M | 42.78M | 45.66M | 61.14M | 101.20M |
| Property, Plant & Equipment | 52.56M | 55.84M | 61.52M | 66.84M | 71.31M | 29.81M |
| Goodwill | 16.61M | |||||
| Other Intangible Assets | 11.37M | 13.14M | 14.39M | 16.04M | 19.76M | 18.80M |
| Other Long-Term Assets | 1.13M | 85.00K | 82.00K | 52.00K | 52.00K | 80.00K |
| Total Assets | 95.88M | 103.58M | 118.77M | 128.59M | 152.26M | 166.51M |
| Accounts Payable | 1.44M | 1.38M | 825.00K | 1.49M | 2.45M | 2.25M |
| Accrued Expenses | 3.39M | 4.23M | 4.05M | 5.26M | 4.04M | 3.85M |
| Current Portion of Long-Term Debt | 4.04M | |||||
| Current Portion of Leases | 1.96M | 1.88M | 1.80M | 1.80M | 2.22M | |
| Current Unearned Revenue | 86.00K | 6.00K | 30.00K | 16.00K | 198.00K | 200.00K |
| Other Current Liabilities | 51.00K | 462.00K | 300.00K | 1.97M | 1.45M | |
| Total Current Liabilities | 6.87M | 7.54M | 11.21M | 8.88M | 10.88M | 7.74M |
| Long-Term Debt | 13.22M | 13.12M | 9.44M | 13.25M | 21.98M | 11.87M |
| Long-Term Leases | 12.23M | 13.27M | 14.88M | 15.40M | 18.11M | |
| Long-Term Deferred Tax Liabilities | 956.00K | 879.00K | 827.00K | 919.00K | 1.22M | 3.15M |
| Other Long-Term Liabilities | 10.00K | 102.00K | 191.00K | 542.00K | ||
| Total Liabilities | 33.28M | 34.81M | 36.38M | 38.55M | 52.38M | 23.31M |
| Common Stock | 1.00K | 1.00K | 1.00K | |||
| Additional Paid-In Capital | 206.11M | 204.56M | 200.92M | 181.82M | 154.89M | 150.74M |
| Retained Earnings | -143.51M | -135.79M | -118.53M | -91.79M | -55.01M | -7.54M |
| Total Common Equity | 62.60M | 68.78M | 82.39M | 90.04M | 99.89M | 143.20M |
| Shareholders' Equity | 62.60M | 68.78M | 82.39M | 90.04M | 99.89M | 143.20M |
| Total Liabilities & Equity | 95.88M | 103.58M | 118.77M | 128.59M | 152.26M | 166.51M |
| Total Debt | 27.41M | 28.27M | 30.17M | 30.46M | 42.31M | 11.87M |
| Net Cash (Debt) | -9.97M | -6.93M | 224.00K | -1.97M | -74.00K | 75.65M |
| Net Cash Per Share | -0.19 | -0.13 | 0.00 | -0.06 | -0.00 | 4.70 |
| Filing Date Shares Outstanding | 53.69M | 53.59M | 53.44M | 40.82M | 28.19M | 28.04M |
| Total Common Shares Outstanding | 53.68M | 53.56M | 53.41M | 40.79M | 28.18M | 28.01M |
| Working Capital | 23.95M | 26.97M | 31.57M | 36.78M | 50.27M | 93.46M |
| Book Value Per Share | 1.17 | 1.28 | 1.54 | 2.21 | 3.54 | 5.11 |
| Tangible Book Value | 51.23M | 55.63M | 68.00M | 74.00M | 80.13M | 107.79M |
| Tangible Book Value Per Share | 0.95 | 1.04 | 1.27 | 1.81 | 2.84 | 3.85 |
| Machinery | 32.77M | 31.32M | 31.03M | 31.21M | 20.29M | 10.66M |
| Construction In Progress | 1.55M | 2.92M | 2.62M | 2.00M | 23.71M | 18.82M |
| Leasehold Improvements | 24.92M | 24.87M | 24.35M | 24.67M | 12.09M | 2.81M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -16.77M | -17.26M | -26.75M | -36.78M | -47.47M | -9.80M |
| Depreciation & Amortization | 6.34M | 6.34M | 6.58M | 5.66M | 3.17M | 2.88M |
| Other Amortization | 186.00K | 220.00K | 394.00K | 498.00K | 278.00K | 134.00K |
| Loss (Gain) From Sale of Assets | 24.00K | 19.00K | 233.00K | 57.00K | 326.00K | 41.00K |
| Asset Writedown & Restructuring Costs | 4.36M | 20.80M | ||||
| Loss (Gain) From Sale of Investments | -404.00K | -614.00K | -344.00K | |||
| Stock-Based Compensation | 2.94M | 3.43M | 3.67M | 4.14M | 3.71M | 1.55M |
| Provision & Write-off of Bad Debts | 24.00K | 68.00K | 130.00K | 21.00K | 25.00K | 235.00K |
| Other Operating Activities | 2.17M | 1.83M | 4.57M | 980.00K | -904.00K | -2.34M |
| Change in Accounts Receivable | -292.00K | -374.00K | -494.00K | 292.00K | 380.00K | -278.00K |
| Change in Inventory | -1.32M | -2.37M | 244.00K | 330.00K | -7.55M | -2.25M |
| Change in Accounts Payable | 248.00K | 470.00K | -594.00K | -773.00K | 572.00K | 270.00K |
| Change in Income Taxes | 22.00K | 1.17M | 229.00K | |||
| Change in Other Net Operating Assets | 572.00K | -407.00K | -29.00K | 2.38M | -1.90M | 263.00K |
| Operating Cash Flow | -6.27M | -8.65M | -12.39M | -18.81M | -27.40M | -9.07M |
| Capital Expenditures | -1.08M | -1.15M | -1.12M | -7.93M | -28.15M | -19.88M |
| Sale of Property, Plant & Equipment | 125.00K | 197.00K | ||||
| Investment in Securities | 9.71M | 11.85M | -26.27M | 1.83M | ||
| Other Investing Activities | 529.00K | |||||
| Investing Cash Flow | 8.63M | 10.70M | -27.27M | -7.74M | -28.15M | -17.52M |
| Long-Term Debt Issued | 1.11M | 15.10M | 22.50M | 10.13M | 11.89M | |
| Long-Term Debt Repaid | -10.00M | |||||
| Net Debt Issued (Repaid) | 1.11M | 15.10M | 12.50M | 10.13M | 11.89M | |
| Issuance of Common Stock | 368.00K | 211.00K | 164.00K | 328.00K | 439.00K | 102.67M |
| Other Financing Activities | -1.00K | -1.17M | -378.00K | -32.00K | -307.00K | -3.77M |
| Financing Cash Flow | 367.00K | 151.00K | 14.89M | 12.80M | 10.27M | 110.79M |
| Net Cash Flow | 2.73M | 2.20M | -24.78M | -13.75M | -45.28M | 84.20M |
| Free Cash Flow | -7.35M | -9.79M | -13.52M | -26.75M | -55.55M | -28.95M |
| Free Cash Flow Margin | -16.83% | -24.17% | -35.81% | -72.91% | -134.11% | -78.46% |
| Free Cash Flow Per Share | -0.14 | -0.18 | -0.29 | -0.84 | -1.98 | -1.80 |
| Levered Free Cash Flow | -735.25K | -2.40M | -3.29M | -16.64M | -43.34M | -21.80M |
| Unlevered Free Cash Flow | -376.25K | -2.17M | -3.26M | -16.61M | -43.62M | -21.57M |
| Cash Interest Paid | 1.43M | 1.46M | 1.55M | 1.75M | 101.00K | 414.00K |
| Cash Income Tax Paid | 2.00K | 39.00K | 8.00K | |||
| Change in Working Capital | -788.00K | -2.68M | -873.00K | 2.25M | -7.33M | -1.77M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 454.13M | 203.41M | 445.12M | 151.91M | 158.66M | 573.68M |
| Enterprise Value | 464.10M | 210.27M | 444.01M | 150.65M | 144.76M | 487.50M |
| Last Close Price | 7.36 | 3.80 | 8.35 | 3.73 | 5.64 | 20.48 |
| PS Ratio | 10.39 | 5.02 | 11.79 | 4.14 | 3.83 | 15.55 |
| PB Ratio | 6.31 | 2.96 | 5.40 | 1.69 | 1.59 | 4.01 |
| P/TBV Ratio | 8.86 | 3.66 | 6.55 | 2.05 | 1.98 | 5.32 |
| EV/Sales Ratio | 10.62 | 5.19 | 11.76 | 4.11 | 3.50 | 13.21 |
| Debt / Equity Ratio | 0.44 | 0.41 | 0.37 | 0.34 | 0.42 | 0.08 |
| Net Debt / Equity Ratio | 0.16 | 0.10 | -0.00 | 0.02 | 0.00 | -0.53 |
| Net Debt / EBITDA Ratio | -1.11 | -0.68 | 0.01 | -0.08 | -0.00 | 8.29 |
| Net Debt / FCF Ratio | -1.36 | -0.71 | 0.02 | -0.07 | -0.00 | 2.61 |
| Asset Turnover | 0.42 | 0.36 | 0.30 | 0.26 | 0.26 | 0.32 |
| Inventory Turnover | 3.94 | 3.91 | 3.32 | 2.21 | 2.71 | 4.29 |
| Quick Ratio | 3.32 | 3.44 | 3.10 | 3.65 | 4.28 | 12.06 |
| Current Ratio | 4.49 | 4.58 | 3.82 | 5.14 | 5.62 | 13.07 |
| Return on Equity (ROE) | -24.19% | -22.83% | -31.02% | -38.73% | -39.05% | -10.02% |
| Return on Assets (ROA) | -9.28% | -9.26% | -12.50% | -13.26% | -11.32% | -6.54% |
| Return on Invested Capital (ROIC) | -20.76% | -20.87% | -28.41% | -31.05% | -34.45% | -20.91% |
| Return on Capital Employed (ROCE) | -17.20% | -17.20% | -23.00% | -24.90% | -20.40% | -7.60% |
| Earnings Yield | -4.25% | -8.48% | -6.01% | -24.21% | -29.92% | -1.71% |
| FCF Yield | -1.62% | -4.81% | -3.04% | -17.61% | -35.01% | -5.05% |
| Buyback Yield / Dilution | -0.99% | -14.41% | -46.91% | -13.30% | -74.57% | -323.29% |